Company Overview
- Website
- syncromune.com
- Employees
- 9
- Industry
- Materials/Manufacturing
- SIC Code
-
8731 - Commercial Physical and Biological Research
Financials & Stats
Revenue
$10B
Recent News & Media
Syncromune® Appoints Industry Veteran Kerri-Ann Millar as Chief Financial Officer to Advance Corporate Growth Initiatives and Clinical Development Program
- Jun 16, 2025
- manilatimes.net
Syncromune Appoints Kerri-Ann Millar as Chief Financial Officer
- Jun 16, 2025
- citybiz.co
Syncromune® Inc. Presents Positive Results from SYNC-T® Therapy SV-102 Phase 1 Metastatic Prostate Cancer Trial at ASCO 2025
- Jun 2, 2025
- manilatimes.net
Syncromune® Announces First Patient Dosed in LEGION-100 Phase 2a Trial of SYNC-T® Therapy SV-102 for Patients with Metastatic Castration-Resistant Prostate Cancer
- May 30, 2025
- fox5sandiego.com
Syncromune
- Apr 2, 2025
- thepharmaletter.com
Syncromune Appoints Zhihong Li, Ph.D., as Chief Regulatory Affairs Officer
- Mar 25, 2025
- citybiz.co
Company Leadership
Syncromune Industry Tags
Companies Similar to Syncromune
Analyze industry trends and opportunities by examining competitors and companies comparable to Syncromune, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 10M | 16 | Bethlehem, PA | 2005 | |
| 10M | 28 | New York, NY | 2013 | |
| 10M | Pittsburgh, PA | |||
| 10M | 8 | Houston, TX | 2011 | |
| 10M | 3 | Cary, NC | 2009 |